Vanderbilt Ingram Cancer Center

  • Vanderbilt University

    My Southern Health: The symptoms of cholangiocarcinoma

    The signs of this rare bile-duct cancer typically go unnoticed at first. Here’s what to know. Read More

    Jul. 13, 2018

  • Vanderbilt University

    Lung cancer patients and advocates visit VUMC research labs

    A group of young lung cancer patients and their family members recently toured research laboratories at Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center (VICC) to learn how investigators are working to find better therapies and possibly a cure for the disease. Read More

    Jun. 14, 2018

  • Jagasia to succeed Neuss as VICC Chief Medical Officer

    Jagasia to succeed Neuss as VICC Chief Medical Officer

    After successfully leading Vanderbilt-Ingram Cancer Center (VICC) through years of growth in patient volumes and enhanced care options, Michael Neuss, MD, Chief Medical Officer of the VICC Clinical Enterprise, is retiring as CMO. Neuss will be succeeded by Madan Jagasia, MBBS, MSCI, MMHC, who has been named to the George and Beverley Rawlings Directorship and is section chief, Hematology and Stem Cell Transplant and director of the Outpatient Stem Cell Clinic. Read More

    Jun. 12, 2018

  • Vanderbilt University

    VUMC and VICC lauded by CEO Roundtable on Cancer for employee support

    For the 10th year in a row Vanderbilt University Medical Center (VUMC) and Vanderbilt-Ingram Cancer Center (VICC) have been named a CEO Cancer Gold Standard employer by the Read More

    May. 31, 2018

  • Vanderbilt University

    Berlin assumes new VICC leadership post

    Jordan Berlin, MD, has been named associate director of Clinical Investigation Strategy and Shared Resources at Vanderbilt-Ingram Cancer Center (VICC). Read More

    May. 29, 2018

  • x-ray of lungs with a suspicious spot highlighted in red

    New method to thwart false positives in CT-lung cancer screening

    A team of investigators led by Fabien Maldonado, MD, associate professor of Medicine at Vanderbilt, and Tobias Peikert, MD, assistant professor of Medicine at Mayo Clinic, Rochester, Minnesota, has identified a new technology to address false positives in CT-based lung cancer screening. The study was published in the latest issue of PLOS One. Read More

    May. 24, 2018

  • Vanderbilt University

    Park named to VICC breast cancer leadership position

      Internationally renowned breast cancer expert Ben Ho Park, MD, PhD, has been named co-leader of the Breast Cancer Research Program, director of Precision Oncology and associate director for Translational Research at Vanderbilt-Ingram Cancer Center. In his academic role, he will serve as professor of Medicine. Ben Ho Park, MD,… Read More

    May. 17, 2018

  • Vanderbilt University

    Grant bolsters kidney cancer immunotherapy research

    W. Kimryn Rathmell, MD, PhD, Cornelius Abernathy Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt-Ingram Cancer Center (VICC), has received a grant to research the role of immunosuppression in the tumor microenvironment for kidney cancer. Read More

    May. 10, 2018

  • Vanderbilt University

    VICC Scientific Retreat shines light on microbiome

    Two Vanderbilt students were honored for their stellar scientific research during the Vanderbilt-Ingram Cancer Center (VICC) Annual Scientific Retreat held May 3 at the Vanderbilt University Student Life Center. Read More

    May. 10, 2018

  • New breast health clinic in Cool Springs makes debut

    New breast health clinic in Cool Springs makes debut

    Patients at high risk for developing breast cancer can now be seen by a team of breast health experts in Cool Springs. The VU Breast Health Cool Springs clinic, located at 324 Cool Springs Blvd., Suite B, Franklin, provides a range of medical services for high-risk individuals. Read More

    May. 3, 2018

  • Vanderbilt University

    Limited Submission Opportunity: 2019 Pew-Stewart Scholars Program

    Vanderbilt-Ingram Cancer Center may nominate one candidate for the 2019 Pew-Stewart Scholars for Cancer Research Program. This program supports assistant professors of outstanding promise in science relevant to the advancement of a cure for cancer. Read More

    Apr. 26, 2018

  • Vanderbilt University

    Ingram sees recent cancer diagnosis as second chance

    “When it’s you, it’s a whole different feeling,” Orrin Ingram said, gazing at logs burning in the fireplace. Read More

    Apr. 19, 2018

  • Vanderbilt University

    Cancer Center’s annual scientific retreat set for May 3

    The potential link between the body’s microbiome and cancer is the topic of this year’s Vanderbilt-Ingram Cancer Center (VICC) Scientific Retreat. The annual event, which features leading cancer investigators from the National Cancer Institute (NCI) and several prominent universities will be held Thursday, May 3, 8 a.m. to 3 p.m. at the Vanderbilt Student Life Center. Read More

    Apr. 18, 2018

  • Vanderbilt University

    Agreement renewal bolsters liver tumor research

    Sirtex Medical Ltd. has renewed a grant award to Dan Brown, MD, professor of Radiology and Radiological Sciences and chief of Interventional Oncology, and his Vanderbilt Health colleagues, for a research program designed to treat patients with liver tumors that cannot be addressed with surgery. Read More

    Apr. 12, 2018

  • VICC breast cancer leaders named Komen Scholars

    VICC breast cancer leaders named Komen Scholars

    Ingrid Mayer, MD, MSCI, Ingram Professor of Cancer Research and leader of the Breast Cancer Research Program at Vanderbilt-Ingram Cancer Center (VICC), has been named a Komen Scholar for her leadership in breast cancer research. Read More

    Apr. 12, 2018

  • Vanderbilt University

    Entertainers’ support strengthens VICC melanoma research efforts

    Henry Paul and Dave Robbins, members of country music group BlackHawk, as well as southern rock band The Outlaws, recently donated $40,000 to Vanderbilt-Ingram Cancer Center (VICC) in support of melanoma research. Since 2006, the band members have generated more than $100,000 for VICC. Read More

    Apr. 12, 2018

  • VICC to host symposium on neurofibromatosis April 21

    VICC to host symposium on neurofibromatosis April 21

    Vanderbilt-Ingram Cancer Center (VICC) will host a special event for patients and families affected by neurofibromatosis (NF), a genetic disorder that can cause tumors in the nervous system. The Neurofibromatosis Patient and Family Symposium will be held Saturday, April 21, 9 a.m. – 1 p.m., at the VICC 8th floor conference center in the Preston Research Building, 2220 Pierce Ave. Read More

    Apr. 12, 2018

  • VICC to host neurofibromatosis event April 21

    VICC to host neurofibromatosis event April 21

    Vanderbilt-Ingram Cancer Center (VICC) will host a special event for patients and families affected by neurofibromatosis (NF), a genetic disorder that can cause tumors in the nervous system. Read More

    Apr. 5, 2018

  • Vanderbilt University

    Cancer immunotherapy drugs linked with more serious heart effects

    Vanderbilt University Medical Center investigators have identified a growing number of serious and sometimes fatal cases of heart problems among cancer patients treated with some forms of immunotherapy. Read More

    Mar. 12, 2018

  • close up of blood vessels

    VICC study sheds new light on Von Hippel-Lindau syndrome

    Investigators at Vanderbilt-Ingram Cancer Center (VICC) and the Virginia Tech Carilion Research Institute (VTCRI) have revealed a gene mutation’s role in Von Hippel-Lindau syndrome, a genetically inherited disease which causes tumor growth in several organs. Read More

    Mar. 8, 2018